# Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies

> **NCT01163526** · — · TERMINATED · sponsor: **Stanford University** · enrollment: 13 (actual)

## Conditions studied

- Neuroendocrine Tumors
- Brain (Nervous System) Cancers
- Colon/Rectal Cancer
- Colon Cancer
- Hepatobiliary Cancers
- Hepatocellular Carcinoma (Hepatoma)
- Liver

## Interventions

- **PROCEDURE:** CT perfusion

## Key facts

- **NCT ID:** NCT01163526
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2010-09
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** accrual
- **Last updated:** 2017-01-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01163526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01163526, "Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01163526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*